Sign in

Vincent Rajkumar, MD

@vincentrk.bsky.social
6.5K followers 13 following 13 posts

Editor in Chief, Blood Cancer Journal; Professor, Mayo Clinic; Associate Editor, Mayo Clinic Proceedings; Oncologist, Cancer Research, Myeloma.

PostsRepliesMedia
Vincent Rajkumar, MD @vincentrk.bsky.social · 18/10/2025
Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM 5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and Figures. www.nejm.org/doi/abs/10.1...
0143
Reposted by Vincent Rajkumar, MD
Megan Weivoda, Ph.D. @megvoda.bsky.social · 09/12/2024
So excited to see this thread on BlueSky, @vincentrk.bsky.social! Thank you as always for your excellent summaries!
1101
Vincent Rajkumar, MD @vincentrk.bsky.social · 22/12/2024
Wow. I’m overwhelmed by the response here. Will post more on here.
2220
Vincent Rajkumar, MD @vincentrk.bsky.social · 08/12/2024
My Annual Updated Myeloma Treatment Algorithms thread. Bookmark! #ASH24 #ASH24VR 1. Newly diagnosed transplant ineligible. Quadruplet unless frail. Maintenance varies by risk stratification.
1336
Vincent Rajkumar, MD @vincentrk.bsky.social · 08/12/2024
My first post here. Holy cow! And I already have followers here! Thanks so much everyone. I’m still trying to figure out how to post on X and here. #ASH24
6360